Status | Study |
Recruiting |
Study Name: Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM) Condition: HAM Date: 2016-11-03 Interventions: Biological: NK cells single in |
Recruiting |
Study Name: Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus Condition: HTLV-1 Date: 2016-08-11 Interventions: Other: Video game The protocol sensorimotor exercises consist of a virtual game that attaches to the Nin |
Not yet recruiting |
Study Name: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Condition: HTLV-I Infections Tropical Spastic Paraparesis Date: 2015-11-16 Interventions: Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Recruiting |
Study Name: Raltegravir for HAM/TSP Condition: HTLV-I Infection Date: 2013-05-21 Interventions: Drug: Raltegravir |
Recruiting |
Study Name: Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1 Condition: HTLV-I Infections Date: 2012-12-14 |
Enrolling by invitation |
Study Name: Urological Physical Therapy in HTLV-1 With Urinary Symptoms Condition: Tropical Spastic Paraparesis HTLV-1 Date: 2012-07-25 Interventions: Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |
Completed |
Study Name: A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder Condition: Overactive Bladder Associated With HTLV-1 Date: 2012-07-11 Interventions: Drug: Propantheline Bromide 15 |
Recruiting |
Study Name: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load Condition: Human T-cell Leukemia Virus Type 1 Infection Date: 2012-01-25 Interventions: Drug: Raltegravir Raltegravir 400 mg po bid |
Completed |
Study Name: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Condition: HTLV-1 Tropical Spastic Paraparesis Date: 2011-11-11 Interventions: Drug: Pentoxifylline Pentoxify |
Completed |
Study Name: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Date: 2011-08-16 Interventions: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |